Newsletter | September 6, 2024

09.06.24 -- How To Determine Country Feasibility For CGT Clinical Trials

SPONSOR

Transforming the Biopharma Supply Chain, eData Solutions for Agility and Manufacturing Efficiency

Watch our engaging webinar to discover how eData empowers biopharma supply chains with process automation, critical analytics, and predictive logistics. Learn how manufacturers can proactively mitigate disruptions and adopt a standardized digital platform for resilient operations. Watch it here.

FOCUS ON CLINICAL TRIALS

How To Determine Country Feasibility For CGT Clinical Trials

By Jessica Cordes, senior consultant and trainer, Clinical Excellence GmbH

Learn how to choose the right location — globally — for your next cell and gene therapy clinical trial.

RNA Therapy Clinical Trials – 2024

White Paper | Novotech

This resource offers a detailed analysis of the global RNA trial landscape, highlighting the growth in trials, especially in the Asia-Pacific region, which has seen a 26% annual growth rate.

‘Diabesitology’: Novel Trial Designs In The GLP-1 Axis Medications Era

Article | By Jamie P. Dwyer, M.D., Biorasi Scientific Advisory Board Member

Find out how today’s FDA-approved obesity medications are primed to become tomorrow’s novel treatments across multidimensional states of disease — from diabetes to heart failure.

The Power Of Patient Engagement With CGT Innovation

Q&A | Cencora

Explore insights from George Eastwood at the ThinkLive Cell and Gene Therapy Summit 2024 on enhancing therapies and advancing patient-centric drug development.

Making Trial Participation Easier For Rare Disease Patients, Families

Q&A | By Rachel Smith, Parexel International

New research highlights several significant challenges sponsors encounter when conducting clinical trials in rare neurological disorders.

How Different Are Oncology Clinical Trials?

Article | OpenClinica

Oncology clinical trials pose unique challenges. Dive into five key reasons behind the intricacies of oncology trials, from recruitment hurdles to data volume and efficacy endpoints.

CLINICAL TRIAL SOLUTIONS

•

Benefits Of A Patient-Centric Design In Oncology Trials - MRN - Medical Research Network

•

An End-To-End Clinical Data Science Platform - Revvity Signals Software, Inc.

FOCUS ON SUPPLY CHAIN

The Challenges With Shipping Cell Therapy Products

In this Cell & Gene Live digital event Stem-Cell Derived Therapies: From Source To Site segment, panelists share several worst-case shipping scenarios they’ve encountered when transporting cellular products.

Evaluation Criteria Of Freezer Systems For Bulk Pharmaceuticals

Webinar | Entegris, Inc.

Review data and evidence that demonstrates the benefits of an integrated approach to achieving critical end-user goals such as scalability, efficiency, sustainability, and optimized process economics.

SUPPLY CHAIN SOLUTIONS

•

Single-Use Flexible Freeze Container - W.L. Gore & Associates

Connect With Cell & Gene: